Literature DB >> 10210630

Can treatment for pure alexia improve letter-by-letter reading speed without sacrificing accuracy?

S Nitzberg Lott1, R B Friedman.   

Abstract

An experimental treatment study designed to improve both the accuracy and the speed of reading was administered to a patient with pure alexia and impaired letter naming. The study focused on the use of letter-by-letter reading. A two-stage approach was employed. The first stage implemented a tactile-kinesthetic strategy to improve accuracy. The second stage concentrated on speed. At the end of the treatment, patient DL was reading both trained and untrained words more accurately and with considerably greater speed than prior to treatment. Accuracy and speed of reading at the sentence level improved as well. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10210630     DOI: 10.1006/brln.1999.2054

Source DB:  PubMed          Journal:  Brain Lang        ISSN: 0093-934X            Impact factor:   2.381


  4 in total

1.  Multimodal alexia: neuropsychological mechanisms and implications for treatment.

Authors:  Esther S Kim; Steven Z Rapcsak; Sarah Andersen; Pélagie M Beeson
Journal:  Neuropsychologia       Date:  2011-09-19       Impact factor: 3.139

2.  Overt use of a tactile-kinesthetic strategy shifts to covert processing in rehabilitation of letter-by-letter reading.

Authors:  Susan Nitzberg Lott; Aimee Syms Carney; Laurie S Glezer; Rhonda B Friedman
Journal:  Aphasiology       Date:  2010-11       Impact factor: 2.773

3.  The neural substrates of improved phonological processing following successful treatment in a case of phonological alexia and agraphia.

Authors:  Andrew T DeMarco; Stephen M Wilson; Kindle Rising; Steven Z Rapcsak; Pélagie M Beeson
Journal:  Neurocase       Date:  2018-01-19       Impact factor: 0.881

Review 4.  Rehabilitation of pure alexia: a review.

Authors:  Randi Starrfelt; Rannveig Rós Olafsdóttir; Ida-Marie Arendt
Journal:  Neuropsychol Rehabil       Date:  2013-06-28       Impact factor: 2.868

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.